[Therapy of various clinical situations especially in the course of Hodgkin's disease]

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Oncology reports·2011

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

Oncology reports·2011

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

International journal of oncology·2011

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

International journal of oncology·2011

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

European journal of cancer (Oxford, England : 1990)·2002

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

Haematologica·2026

In vivo efficacy of the novel anti-microtubule inhibitor E7130 in preclinical models of early T-cell precursor acute lymphoblastic leukemia.

Haematologica·2026

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Haematologica·2026

Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection.

Haematologica·2026

Degrading the BTK and blocking BCL2: a new path in marginal zone lymphomas.

Haematologica·2026

Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies.

Haematologica·2026

Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China.

Frontiers in public health·2026

IL-2 and CD40L can establish and sustain a human B cell-mediated immune regulatory network.

bioRxiv : the preprint server for biology·2026

A 28-color panel for classical and non-classical T lymphocytes in decidua and PBMC in rhesus macaques.

bioRxiv : the preprint server for biology·2026

[pMHCBind: predicting major histocompatibility complex class I-peptide interactions via protein large language models and hypergraph neural networks].

Sheng wu gong cheng xue bao = Chinese journal of biotechnology·2026

Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine.

Neurology and therapy·2026

Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study.

Rheumatology and therapy·2026

Related Experiment Videos

[Therapy of various clinical situations especially in the course of Hodgkin's disease]

Related Concept Videos

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

Mitochondrial dysfunction in Down syndrome B-cell acute lymphoblastic leukemia can be targeted using venetoclax.

In vivo efficacy of the novel anti-microtubule inhibitor E7130 in preclinical models of early T-cell precursor acute lymphoblastic leukemia.

Menin inhibition with revumenib clears measurable residual disease in acute myeloid leukemia with UBTF tandem duplication after allogeneic stem cell transplantation.

Risk of immune thrombocytopenia following COVID-19 vaccination and SARS-CoV-2 infection.

Degrading the BTK and blocking BCL2: a new path in marginal zone lymphomas.

Human cell models for inherited platelet disorders: strengths, limitations and emerging technologies.

Rabies immunoglobulin utilization and delayed presentation following category III rabies exposure: a 10-year retrospective study in Hangzhou, China.

IL-2 and CD40L can establish and sustain a human B cell-mediated immune regulatory network.

A 28-color panel for classical and non-classical T lymphocytes in decidua and PBMC in rhesus macaques.

[pMHCBind: predicting major histocompatibility complex class I-peptide interactions via protein large language models and hypergraph neural networks].

Current and Emerging Therapies for Generalized Myasthenia Gravis: Toward Precision Medicine.

Bimekizumab in Chinese Patients with Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results from the Phase 3 BE MOBILE 1 Study.

Related Experiment Videos

[Therapy of various clinical situations especially in the course of Hodgkin's disease]

Related Concept Videos

Related Articles